P4HB Maintains Wnt-Dependent Stemness in Glioblastoma Stem Cells as a Precision Therapeutic Target and Serum Marker

Using bioinformatics and experimental analysis, scientists identified P4HB, a protein disulfide isomerase, as a serum marker that maintains stemness in glioblastoma stem cells through the Wnt/β-catenin signaling pathway.